Meyka Pro banner
Vericel Corporation

Vericel Corporation Fundamental Analysis (NASDAQ: VCEL)

VCELNASDAQ
HealthcareBiotechnology
$43.22
$0.92(2.17%)
U.S. Market opens in 11h 9m

Vericel Corporation Fundamental Analysis (NASDAQ: VCEL)

Vericel Corporation (NASDAQ: VCEL) shows weak financial fundamentals with a PE ratio of 89.73, profit margin of 7.91%, and ROE of 6.91%. The company generates $0.3B in annual revenue with strong year-over-year growth of 16.45%.

Key Strengths

PEG Ratio0.37
Current Ratio5.04

Areas of Concern

ROE6.91%
Operating Margin5.95%
We analyze VCEL's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of 58.3/100 based on profitability, valuation, growth, and balance sheet metrics. The C grade reflects average fundamentals, with notable risks in certain areas.

Fundamental Health Score

C
58.3/100

We analyze VCEL's fundamental strength across five key dimensions:

Efficiency Score

Weak

VCEL struggles to generate sufficient returns from assets.

ROA > 10%
4.82%

Valuation Score

Moderate

VCEL shows balanced valuation metrics.

PE < 25
89.73
PEG Ratio < 2
0.37

Growth Score

Excellent

VCEL delivers strong and consistent growth momentum.

Revenue Growth > 5%
16.45%
EPS Growth > 10%
57.14%

Financial Health Score

Excellent

VCEL maintains a strong and stable balance sheet.

Debt/Equity < 1
0.25
Current Ratio > 1
5.04

Profitability Score

Weak

VCEL struggles to sustain strong margins.

ROE > 15%
6.91%
Net Margin ≥ 15%
7.91%
Positive Free Cash Flow
Yes

Key Financial Metrics

Is VCEL Expensive or Cheap?

P/E Ratio

VCEL trades at 89.73 times earnings. This suggests a premium valuation.

89.73

PEG Ratio

When adjusting for growth, VCEL's PEG of 0.37 indicates potential undervaluation.

0.37

Price to Book

The market values Vericel Corporation at 5.93 times its book value. This suggests the stock is fully valued or overvalued on an asset basis.

5.93

EV/EBITDA

Enterprise value stands at 58.21 times EBITDA. This signals the market has high growth expectations.

58.21

How Well Does VCEL Make Money?

Net Profit Margin

For every $100 in sales, Vericel Corporation keeps $7.91 as profit after all expenses.

7.91%

Operating Margin

Core operations generate 5.95 in profit for every $100 in revenue, before interest and taxes.

5.95%

ROE

Management delivers $6.91 in profit for every $100 of shareholder equity.

6.91%

ROA

Vericel Corporation generates $4.82 in profit for every $100 in assets, demonstrating efficient asset deployment.

4.82%

Following the Money - Real Cash Generation

Operating Cash Flow

Vericel Corporation produces operating cash flow of $70.06M, showing steady but balanced cash generation.

$70.06M

Free Cash Flow

Vericel Corporation generates strong free cash flow of $49.91M, providing ample flexibility for dividends, buybacks, or growth.

$49.91M

FCF Per Share

Each share generates $0.97 in free cash annually.

$0.97

FCF Yield

VCEL converts 2.25% of its market value into free cash.

2.25%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

89.73

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

0.37

vs 25 benchmark

P/B Ratio

Price to book value ratio

5.93

vs 25 benchmark

P/S Ratio

Price to sales ratio

7.20

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

0.25

vs 25 benchmark

Current Ratio

Current assets to current liabilities

5.04

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

0.07

vs 25 benchmark

ROA

Return on assets percentage

0.05

vs 25 benchmark

ROCE

Return on capital employed

0.04

vs 25 benchmark

How VCEL Stacks Against Its Sector Peers

MetricVCEL ValueSector AveragePerformance
P/E Ratio89.7332.14 Worse (Expensive)
ROE6.91%550.00% Weak
Net Margin7.91%30133.00% Weak
Debt/Equity0.250.56 Strong (Low Leverage)
Current Ratio5.045.70 Strong Liquidity
ROA4.82%3.00% Excellent

VCEL outperforms its industry in 3 out of 6 key metrics, particularly excelling in ROA, but lagging in P/E Ratio.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Vericel Corporation's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

98.85%

Industry Style: Defensive, Growth, Innovation

High Growth

EPS CAGR

415.53%

Industry Style: Defensive, Growth, Innovation

High Growth

FCF CAGR

164.06%

Industry Style: Defensive, Growth, Innovation

High Growth

Fundamental Analysis FAQ